mRNA |
MS-275 |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.2 |
mRNA |
BMS-536924 |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
BRD-K24690302 |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |
mRNA |
AZD8055 |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.2 |
mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.2 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.2 |
mRNA |
LE-135 |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.2 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.2 |